Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
H3 histone pseudogene 19 | 0.631 | 0.577 |
|
group | 0.100 | None | 0.900 | 30 | 0 | 1990 | 2019 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
group | 0.100 | None | 0.944 | 18 | 0 | 1999 | 2019 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
group | 0.100 | None | 0.944 | 18 | 0 | 1999 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
group | 0.100 | None | 0.909 | 11 | 0 | 2003 | 2019 | |||||||||
|
killer cell immunoglobulin like receptor, three Ig domains and short cytoplasmic tail 1 | 0.617 | 0.692 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2008 | 2019 | |||||||||
|
endogenous retrovirus group K member 20 | 0.533 | 0.692 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2000 | 2017 | |||||||||
|
endogenous retrovirus group W member 1, envelope | 0.505 | 0.692 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2000 | 2017 | |||||||||
|
endogenous retrovirus group K member 6, envelope | 0.521 | 0.808 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2000 | 2017 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2000 | 2017 | |||||||||
|
immunoglobulin heavy variable 3-75 (pseudogene) | 0.769 | 0.231 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1994 | 2004 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | 0.537 | 0.769 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2019 | |||||||||
|
Bornholm eye disease | 0.729 | 0.308 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2008 | 2017 | |||||||||
|
HLA complex P5 | 0.595 | 0.808 |
|
group | 0.040 | None | 1.000 | 4 | 1 | 2008 | 2011 | |||||||||
|
endogenous retrovirus group K member 32, envelope | 0.522 | 0.692 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2000 | 2017 | |||||||||
|
sex determining region Y | 0.456 | 0.808 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2017 | |||||||||
|
endogenous retrovirus group K member 2 | 0.674 | 0.423 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2019 | |||||||||
|
endogenous retrovirus group K member 12 | 0.678 | 0.423 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2019 | |||||||||
|
endogenous retrovirus group K member 22 | 0.678 | 0.423 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2019 | |||||||||
|
endogenous retrovirus group K member 18 | 0.560 | 0.654 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2017 | |||||||||
|
endogenous retrovirus group K member 11 | 0.663 | 0.423 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2019 | |||||||||
|
interferon lambda 4 (gene/pseudogene) | 0.670 | 0.577 |
|
group | 0.020 | None | 1.000 | 2 | 2 | 2018 | 2018 | |||||||||
|
H3 histone pseudogene 28 | 0.553 | 0.692 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2004 | |||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
interferon, type 1, cluster | 0.565 | 0.731 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 |